SickleFit Exercise and Nutrition Study
The SickleFit Exercise and Nutrition Randomized Control Trial for Older Adults With Sickle Cell Disease
1 other identifier
interventional
40
1 country
1
Brief Summary
To goal of this study is to pilot the SickleFit exercise and nutrition intervention in adults with sickle cell disease in a randomized control trial
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2026
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedStudy Start
First participant enrolled
April 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
May 7, 2026
May 1, 2026
1.7 years
February 20, 2026
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Feasibility of Randomization
Feasibility of randomization (proportion of participants randomized out of those approached)
From enrollment to the last paticipants randomized over a 2 year period
Safety/Adverse Events
number of life-threatening adverse events
adverse events will be measured for both arms up to 6 months
Acceptability
Proportion of participants reporting satisfaction with the program
From enrollment to after completion of the SickleFit Program over 6 months since we will also measure acceptability for control group
Retention in the program
retention (proportion of the SickleFit and control groups completing follow up assessment)
From the baseline Sickle Cell Disease Functional Assessment to the post-SCD-FA. Over a 30 week period since post assessments will be completed within 3 months of completion of the SickleFit program or control period.
Adherence
Adherence (proportion attending ≥ 50% of classes) in the SickleFit arm
From the start of the first SickleFit session to the end of the SickleFit program at 12 weeks
Other Outcomes (1)
Performance on the Sickle Cell Disease Functional Assessment (SCD-FA)
From baseline assessment to completion of the post-assessment within 6 months
Study Arms (2)
SickleFit arm
EXPERIMENTALParticipants in SickleFit arm will complete the Sickle Cell Disease Functional Assessment before and after 12 weeks of SickleFit exeercise+Nutrition intervention.
Control Arm
NO INTERVENTIONParticipants in the control arm will be on a wait list for SickleFit and will continue to receive usual care during that 12-week period. They will complete the Sickle Cell Disease Functional Assessment at baseline and after 12 weeks on the wait list. After their post-assessment, they will have the option to complete 12 weeks of SickleFit exercise+Nutrition intervention.
Interventions
SickleFit personalized exercise plus dietitian-facilitated nutrition intervention
Eligibility Criteria
You may qualify if:
- Laboratory-confirmed diagnosis of sickle cell disease (any genotype)
- Understand and speak English by self-report
- Age ≥ 35 years old
You may not qualify if:
- Oxygen dependence
- Unstable cardiac disease
- Wheelchair-bound
- Diagnosed with severe cognitive impairment based on ICD-10 codes or reported by their outpatient provider
- Unable to self-consent
- Severe uncorrected visual or auditory impairment
- Pregnant
- Successfully treated with hematopoietic stem cell transplantation or gene therapy for sickle cell disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University
Durham, North Carolina, 27710, United States
Related Publications (1)
Charity I Oyedeji, Teagan Callaway, Rania Mohamed, Reena Ravi, Richard Faldowski, Corey Vessels, Miriam C Morey, John J Strouse; The Sicklefit Exercise Program for Older Adults with Sickle Cell Disease: Feasibility, Acceptability, and Safety. Blood 2024; 144 (Supplement 1): 604. doi: https://doi.org/10.1182/blood-2024-212100
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charity I Oyedeji, MD
Duke University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2026
First Posted
March 2, 2026
Study Start
April 8, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2028
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share